Biotechnology company Advanced Enzyme Technologies announced Q1FY26 results Revenue from operations on consolidated basis increased to Rs 1,859 million in the Q1FY26 from Rs 1,545 million in the Q1FY25, a growth of 20%. Consolidated EBITDA during Q1FY26 stands at Rs 564 million as compared to Rs 512 million during Q1FY25, an increase of 10%. EBITDA margin stands at 30%, PBT margin stands at 30% and PAT margin stands at 22% during the quarter. Profit before tax stands at Rs 549 million during Q1FY26 as against Rs 487 million in Q1FY25, an increase of 13%. Profit after tax grew by 16% and stands at Rs 404 million during Q1FY26 as compared to Rs 350 million during the Q1FY25. Financial costs stood at Rs 8 million during Q1FY26 as against Rs 9 million in Q1FY25. Depreciation and Amortization charge for the Q1FY26 stood at Rs 96 million as compared to Rs 86 million in Q1FY25. Earnings Per Share during Q1FY26 stands at Rs 3.57 as compared to Rs 3.05 in Q1FY25. Result PDF